Senior Scientist, Clinical Biomarker Operations, Translational Sciences-Immunology at Johnson & Johnson

Spring House, Pennsylvania, United States

Johnson & Johnson Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Highly motivated individual with experience in clinical biomarker and diagnostic strategy
  • Accountability for implementation and execution of clinical sample collection, testing, and data delivery activities for early and late phase clinical programs in Immunology
  • Experience bridging science and operations through cross-functional partnerships
  • Expertise in strategic project planning and facilitating key biomarker delivery
  • Background in Translational Sciences, particularly in biomarker development, disease biology research, and application of immunology and data science technologies
  • Ability to integrate human-based data and tissues to support end-to-end portfolio from discovery to clinical development
  • Location: Spring House, Pennsylvania, United States of America

Responsibilities

  • Serve as a key contributor to the clinical biomarker and diagnostic strategy in the Immunology therapeutic area
  • Implement and execute clinical sample collection, testing, and data delivery for early and late phase clinical programs
  • Bridge Discovery Research and later phase Clinical Development through scientific and clinical expertise
  • Support discovery with human data for target selection
  • Develop novel decision-making biomarkers for early phase clinical trials
  • Provide target-centric indication sequencing and prioritization
  • Deliver biomarker support for regulatory filings
  • Foster cross-functional partnerships and strategic project planning to advance novel mechanism small molecules and biologic agents for immune-mediated diseases

Skills

Biomarkers
Clinical Operations
Translational Sciences
Immunology
Clinical Development
Biomarker Development

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters
1886Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.
Former J&J executives joining other firms could lead to increased competition.
Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.
The company invests heavily in R&D for innovative medical solutions and products.
J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.
The rise of personalized medicine offers J&J opportunities in targeted therapies.
Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI